Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.31B P/E - EPS this Y 68.60% Ern Qtrly Grth -
Income -145.93M Forward P/E -12.87 EPS next Y 51.40% 50D Avg Chg -9.00%
Sales 382.24M PEG -0.46 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book N/A EPS next 5Y 44.80% 52W High Chg -55.00%
Recommedations 1.90 Quick Ratio 2.64 Shares Outstanding 206.89M 52W Low Chg 3.00%
Insider Own 1.15% ROA -6.91% Shares Float 192.20M Beta 1.88
Inst Own 86.61% ROE - Shares Shorted/Prior 24.32M/24.81M Price 6.95
Gross Margin 47.06% Profit Margin -38.18% Avg. Volume 2,556,691 Target Price 14.45
Oper. Margin 8.01% Earnings Date Oct 31 Volume 5,164,701 Change -0.29%
About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BioCryst Pharmaceuticals, Inc. News
11/18/24 BioCryst Launches ORLADEYO® (berotralstat) in Ireland
11/06/24 BioCryst to Present at Upcoming Investor Conferences
11/05/24 BioCryst Announces Strong Q3 2024 Revenue Growth
11/05/24 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/05/24 BioCryst Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
11/05/24 Q3 2024 BioCryst Pharmaceuticals Inc Earnings Call
11/05/24 BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...
11/04/24 BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript
11/04/24 BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates
11/04/24 BioCryst: Q3 Earnings Snapshot
11/04/24 BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
10/24/24 BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)
10/23/24 How Much Upside is Left in BioCryst (BCRX)? Wall Street Analysts Think 79.5%
10/23/24 High Growth Tech Stocks To Watch In October 2024
06:00 AM BioCryst to Report Third Quarter 2024 Financial Results on November 4
10/14/24 BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat)
10/11/24 Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler?
10/10/24 BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting
10/09/24 BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2
10/07/24 BioCryst (BCRX) Upgraded to Buy: Here's Why
BCRX Chatroom

User Image gdesivir Posted - 14 minutes from now

$BCRX Held ARNA for 4+ years before selling off. Company got acquired within a year after that. Holding this for 4+ years now won’t sell this time ….

User Image steven1x Posted - 5 hours ago

$BCRX if missed https://wsw.com/webcast/jeff315/register.aspx?conf=jeff315&page=bcrx&url=https://wsw.com/webcast/jeff315/bcrx/1849260

User Image TheVulcanDevilWhale Posted - 5 hours ago

$BCRX Wen 8.22 🖖🏽😈🐳

User Image Bigmike50 Posted - 6 hours ago

@The_Singularity you still high on $BCRX ?

User Image fergus0123 Posted - 8 hours ago

$BCRX lol 5 shares

User Image fergus0123 Posted - 8 hours ago

$BCRX how many shares AH for the jump? 4?

User Image fergus0123 Posted - 9 hours ago

$CLSD anything associated with $BCRX is doomed.

User Image HoweDy Posted - 10 hours ago

$BCRX Anyone else feel like they are in prison?

User Image Jccjax Posted - 10 hours ago

$BCRX I have only been investing for about three years or so, hit a small stroke of luck on GameStop back during the original pump and rolled it all into BCRX. since then, have had basically all my proceeds locked into this stupid fucking stock. It sucks. I’m not even convinced we’re going to be 10+ at 1 billion sales of orla

User Image coleslaugh Posted - 13 hours ago

$BCRX for a brief moment this morning, i thought maybe we were headed up to the mid 8s by month’s end and could retest 10 in january. i may have been too optimistic.

User Image fergus0123 Posted - 13 hours ago

$BCRX its so stupid

User Image fergus0123 Posted - 13 hours ago

$BCRX its so rigged

User Image justfkntrade Posted - 13 hours ago

$BCRX can’t stay up to save its life :(

User Image fergus0123 Posted - 13 hours ago

$BCRX its so pathetic

User Image JPtheBCRXdestroyer1 Posted - 15 hours ago

$BCRX https://www.fiercepharma.com/financials/gilead-s-hep-c-guidance-comes-far-short-expectations-as-abbvie-s-mavyret-scoops-up-share

User Image WKNDatBERNIES Posted - 16 hours ago

$BCRX let’s get up to $8+ so my wife’s boyfriend can stop flexing his 0.15% interest rate on his checking account.

User Image BirdStar Posted - 16 hours ago

$BCRX

User Image YerbMe Posted - 16 hours ago

$BCRX 🚀🚀🚀

User Image jw356 Posted - 17 hours ago

$BCRX 17 open positions on website from interns to directors. Just get to profitability sooner rather than later. Keep beating guidance, and the timing on profitability. Get this pps into double digits. And sustain cash flow positivity once it gets here.

User Image fergus0123 Posted - 17 hours ago

$BCRX another beautiful day

User Image Iwillbuy Posted - 17 hours ago

$BCRX here is what’s happening to many stocks on the internet… Going to come to an end sooner than later! SEC is watching now… https://youtu.be/sxRNhzOXqPs

User Image fergus0123 Posted - 18 hours ago

$BCRX pure crap

User Image WKNDatBERNIES Posted - 18 hours ago

$BCRX

User Image fergus0123 Posted - 20 hours ago

$BCRX another day with no buyout news.

User Image clownmarket Posted - 20 hours ago

$BCRX FYI not much new in the Jeffries talk. They put some emphasis on the monte carlo simulation and market research they put in the Q3 ER, and their confidence in it, made the point that companies don't usually show that sort of information. They seemed slightly annoyed no one really picked up on what those slides were saying - I sympathise with that I guess there is a bit more detail on Netherton but this wasn't essential viewing

User Image fergus0123 Posted - 20 hours ago

$BCRX @Stocktwits $0 again and still 28 week old news. This app is legitimately terrible.

User Image fergus0123 Posted - 1 day ago

$BCRX when is our R and D day? I’m in the mood for a 35% haircut.

User Image Geex Posted - 1 day ago

$BCRX I honestly think we’re going 10+ very soon

User Image Geex Posted - 1 day ago

$BCRX chart looking like ballsack

User Image Peter_Thornton Posted - 1 day ago

$BCRX is the floor at this point $7?

Analyst Ratings
JMP Securities Market Outperform Aug 6, 24
Barclays Equal-Weight Aug 6, 24
RBC Capital Outperform Aug 6, 24
HC Wainwright & Co. Buy Aug 6, 24
JMP Securities Market Outperform May 7, 24
HC Wainwright & Co. Buy May 7, 24
Needham Buy May 7, 24
Needham Buy Apr 10, 24
Needham Buy Jan 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Stonehouse Jon P President & CEO President & CEO Feb 01 Sell 10.38 100,000 1,038,000 1,008,739 02/02/23
Stonehouse Jon P President & CEO President & CEO Feb 01 Option 5.45 100,000 545,000 1,108,739 02/02/23
LEE KENNETH B JR Director Director Jan 31 Option 1.71 15,000 25,650 52,118 02/02/23
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Option 3.22 148,302 477,532 199,093 03/14/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Sell 17.26 161,139 2,781,259 37,954 03/14/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Option 4.73 2,300 10,879 13,498 03/03/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Sell 17.2 2,300 39,560 11,198 03/03/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Option 4.73 184,000 870,320 1,085,602 01/13/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Sell 15.04 184,000 2,767,360 901,602 01/13/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Option 5.26 163,573 860,394 106,289 06/01/21
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Sell 15.01 163,573 2,455,231 14,475 06/01/21
Barnes Alane P Senior VP, Chief Leg.. Senior VP, Chief Legal Officer Dec 15 Option 4.15 13,741 57,025 121,802 12/15/20